- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06272838
Biodex Balance System in Patients With Parkinson's Disease
February 16, 2024 updated by: Basak Cigdem Karacay, Kirsehir Ahi Evran Universitesi
The Effectiveness of the Exercise Program Applied With the Biodex Balance System in Patients With Parkinson's Disease
Conventional balance exercises are an effective rehabilitation method applied in routine rehabilitation programs for Parkinson's patients.
With technological developments, balance exercises
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study was planned based on the hypothesis that exercises based on visual feedback applied to patients through games will increase patient compliance and improve balance better than conventional exercise.Previous studies have shown that the Biodex balance device has positive contributions to balance in neurological and orthopedic rehabilitation applications.
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Basak Cigdem Karacay, Asst Prof
- Phone Number: +9 0386 280 51 00.
- Email: basakcigdem@hotmail.com
Study Locations
-
-
City Center
-
Kırşehir, City Center, Turkey, 40100
- Recruiting
- Kırşehir Ahi Evran University Faculty of Medicine
-
Contact:
- Basak Cigdem Karacay, Asist Prof
- Phone Number: 0905445094803
- Email: basak.cigdemkaracay@ahievran.edu.tr
-
Principal Investigator:
- Basak Cigdem Karacay, Asist Prof
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Parkinson's diagnosis and Hoehn Yahr stage I-III
- Not changing medical treatment in the last three months
- Mini mental test score is over twenty-four
Exclusion Criteria:
- Vestibular hypofunction
- Neurological disease other than Parkinson's disease (multiple sclerosis, stroke, myopathy)
- History of lower extremity surgery (such as arthroplasty, anterior cruciate ligament repair)
- Upper limb amputation in the participant
- Impairment in cognitive functions
- History of psychotic illness
- Presence of stage 4 gonarthrosis history of malignancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Group
In addition to conventional balance exercises, the exercise program, which includes games to improve balance, performed with the help of a Biodex balance device, will be given in a total of 20 sessions, 5 days a week, for 4 weeks..
|
In addition to the conventional exercise program, it will be applied on a platform with the Biodex balance system for 4 weeks, 5 days a week, in a total of 20 sessions.
The conventional balance exercise program will be applied by a physiotherapist for 4 weeks, 5 days a week, in a total of 20 sessions.
|
|
Active Comparator: Control Group
The conventional balance exercise program will be applied by a physiotherapist for 4 weeks, 5 days a week, in a total of 20 sessions.
|
The conventional balance exercise program will be applied by a physiotherapist for 4 weeks, 5 days a week, in a total of 20 sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berg Balance Scale
Time Frame: Baseline
|
Berg Balance Scale was developed to measure balance performance and is used to evaluate postural control and predict fall risk.
Higher scores indicate better balance
|
Baseline
|
|
Berg Balance Scale
Time Frame: 4th week
|
Berg Balance Scale was developed to measure balance performance and is used to evaluate postural control and predict fall risk.
Higher scores indicate better balance
|
4th week
|
|
Berg Balance Scale
Time Frame: 8 th week
|
Berg Balance Scale was developed to measure balance performance and is used to evaluate postural control and predict fall risk.
Higher scores indicate better balance
|
8 th week
|
|
Biodex dynamic balance score
Time Frame: Baseline
|
The balance assessment of the participants will be made with the Biodex Balance Systems device.
During the measurement, patients will try to stay balanced on the device whose platform stability is adjusted.
|
Baseline
|
|
Biodex dynamic balance score
Time Frame: 4th week
|
The balance assessment of the participants will be made with the Biodex Balance Systems device.
During the measurement, patients will try to stay balanced on the device whose platform stability is adjusted.
|
4th week
|
|
Biodex dynamic balance score
Time Frame: 8th week
|
The balance assessment of the participants will be made with the Biodex Balance Systems device.
During the measurement, patients will try to stay balanced on the device whose platform stability is adjusted.
|
8th week
|
|
The fall efficacy scale
Time Frame: Baseline
|
The fall efficacy scale consists of 10 questions rated on a 10-point Likert scale.
Getting more than 70 points from the scale indicates fear of falling.
|
Baseline
|
|
The fall efficacy scale
Time Frame: 4th week
|
The fall efficacy scale consists of 10 questions rated on a 10-point Likert scale.
Getting more than 70 points from the scale indicates fear of falling.
|
4th week
|
|
The fall efficacy scale
Time Frame: 8th week
|
The fall efficacy scale consists of 10 questions rated on a 10-point Likert scale.
Getting more than 70 points from the scale indicates fear of falling.
|
8th week
|
|
Time up and go test
Time Frame: Baseline
|
Time up and go testing will be performed to determine fall risk and measure balance, sit-to-stand and walking progress.
Minimal detectable change in Parkinson's patients.
It is 3.5 seconds.
(10.2522/ptj.20090126.)
|
Baseline
|
|
Time up and go test
Time Frame: 4th week
|
Time up and go testing will be performed to determine fall risk and measure balance, sit-to-stand and walking progress.
Minimal detectable change in Parkinson's patients.
It is 3.5 seconds.
(10.2522/ptj.20090126.)
|
4th week
|
|
Time up and go test
Time Frame: 8th week
|
Time up and go testing will be performed to determine fall risk and measure balance, sit-to-stand and walking progress.
Minimal detectable change in Parkinson's patients.
It is 3.5 seconds.
(10.2522/ptj.20090126.)
|
8th week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8)
Time Frame: Baseline
|
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8)is a shortened version of the 39-item Parkinson's Disease Questionnaire (PDQ-39).
It is a patient-reported outcome measure used to measure people's quality of life.
It consists of 8 questions, each question is scored between 0-4.
Higher scores indicate worse quality of life.
|
Baseline
|
|
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8)
Time Frame: 4th week
|
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8)is a shortened version of the 39-item Parkinson's Disease Questionnaire (PDQ-39).
It is a patient-reported outcome measure used to measure people's quality of life.
It consists of 8 questions, each question is scored between 0-4.
Higher scores indicate worse quality of life.
|
4th week
|
|
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8)
Time Frame: 8th week
|
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8)is a shortened version of the 39-item Parkinson's Disease Questionnaire (PDQ-39).
It is a patient-reported outcome measure used to measure people's quality of life.
It consists of 8 questions, each question is scored between 0-4.
Higher scores indicate worse quality of life.
|
8th week
|
|
The Five Times Sit to Stand Test
Time Frame: 8th week
|
The Five Times Sit to Stand Test measures one aspect of transfer skill.
The test provides a method to quantify functional lower extremity strength and/or identify movement strategies a patient uses to complete transitional movements.
The patient is asked to stand up quickly and sit down 5 times and the time is recorded.
|
8th week
|
|
The Five Times Sit to Stand Test
Time Frame: 4th week
|
The Five Times Sit to Stand Test measures one aspect of transfer skill.
The test provides a method to quantify functional lower extremity strength and/or identify movement strategies a patient uses to complete transitional movements.
The patient is asked to stand up quickly and sit down 5 times and the time is recorded.
|
4th week
|
|
The Five Times Sit to Stand Test
Time Frame: baseline
|
The Five Times Sit to Stand Test measures one aspect of transfer skill.
The test provides a method to quantify functional lower extremity strength and/or identify movement strategies a patient uses to complete transitional movements.
The patient is asked to stand up quickly and sit down 5 times and the time is recorded.
|
baseline
|
|
Beck Depression Inventory
Time Frame: baseline
|
Beck depression inventory can be self-scored.
It consists of 21 questions.
Higher scores indicate increased depression.
|
baseline
|
|
Beck Depression Inventory
Time Frame: 4th week
|
Beck depression inventory can be self-scored.
It consists of 21 questions.
Higher scores indicate increased depression.
|
4th week
|
|
Beck Depression Inventory
Time Frame: 8th week
|
Beck depression inventory can be self-scored.
It consists of 21 questions.
Higher scores indicate increased depression.
|
8th week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Basak Cigdem Karacay, Asst Prof, Kirsehir Ahi Evran University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ramos GS, Silva-Batista C, Palma BP, Ugrinowitsch C, Cunha TFD. Risk of falls using the Biodex Balance System in non-faller patients with Parkinson Disease. Somatosens Mot Res. 2022 Jun-Dec;39(2-4):111-115. doi: 10.1080/08990220.2021.2018295. Epub 2021 Dec 21.
- de Oliveira Lira JL, Ugrinowitsch C, Fecchio R, Coelho DB, Moreira-Neto A, Germano R, de Lima Miliatto AC, Dos Santos Vieira Yano BC, Silva-Batista C. Minimal Detectable Change for Balance Using the Biodex Balance System in Patients with Parkinson Disease. PM R. 2020 Mar;12(3):281-287. doi: 10.1002/pmrj.12216. Epub 2019 Aug 23.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 28, 2024
Primary Completion (Estimated)
September 14, 2024
Study Completion (Estimated)
October 14, 2024
Study Registration Dates
First Submitted
February 15, 2024
First Submitted That Met QC Criteria
February 16, 2024
First Posted (Actual)
February 22, 2024
Study Record Updates
Last Update Posted (Actual)
February 22, 2024
Last Update Submitted That Met QC Criteria
February 16, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-19/145
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Biodex balance system
-
October 6 UniversityCompletedCOVID-19 Respiratory InfectionEgypt
-
Cairo UniversityNot yet recruitingBody Balnace and Calcaneal FracturesEgypt
-
Duygu AKTAR REYHANIOGLUCompletedDiabetes Mellitus | Diabetic Neuropathies | Exercise TrainingTurkey
-
Bezmialem Vakif UniversityCompletedGait Disorders in Children | Balance | Postural Stability | Postural Control | Femoral AnteversionTurkey
-
Bezmialem Vakif UniversityCompletedGait Disorders in Children | Balance | Postural Stability | Postural Control | Idiopathic Toe WalkingTurkey
-
Riphah International UniversityCompleted
-
Cairo UniversityCompleted
-
Bezmialem Vakif UniversityCompletedObstructive Sleep ApneaTurkey
-
Cairo UniversityMTI UniversityNot yet recruiting